| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| LaPlume Joseph W | EVP, Corp Strategy & Develop | C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON | /s/ Joseph W. LaPlume | 03 Feb 2026 | 0001767215 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRL | Common Stock | Award | $0 | +5,456 | +23% | $0.000000 | 29,172 | 30 Jan 2026 | Direct | F1 |
| transaction | CRL | Common Stock | Tax liability | $370,228 | -1,749 | -6% | $211.68 | 27,423 | 30 Jan 2026 | Direct |
| Id | Content |
|---|---|
| F1 | Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 26, 2023. |